Minovi A, Nowak C, Marek A, Hansen S, Dazert S, Brors D
Universitätsklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Ruhr-Universität Bochum, St. Elisabeth Hospital, Bochum, Germany.
Laryngorhinootologie. 2009 Jan;88(1):18-22. doi: 10.1055/s-2008-1077312. Epub 2008 Jul 16.
This study was designed to assess the postoperative quality of life (QoL) of 30 patients successfully treated with a laryngectomy.
QoL was evaluated with two validated questionnaires (EORTC-QLQ-C30 and EORTC-QLQ-H&N35) during the regular outpatient follow-up. To analyse the long-term quality of life, we divided our collective into two groups of patients; one consisting of patients whose treatment had been completed less than five years ago and one whose therapy had been finished more than five years ago.
The collective consisted of 24 men (80 %) and 6 (20 %) women with a mean age of 58.8 +/- 8.7 years. Mean follow-up was 53 months (range: 12 - 110). Most patients (n = 15, 50 %) had a tumor stadium IV after UICC. Voice rehabilitation was achieved in all patients with a Provoxreg voice prosthesis. The global QoL was rated as satisfying with a mean value of 62. The analysis of the specific questionnaire showed mostly a limitation of smell. Patients, whose treatment was longer than five years ago, showed a slight improvement in the global QoL. Overall we could not find a significant difference concerning the QoL between the two groups.
In our study the QoL of laryngectomized patients was satisfying. The most common symptoms were problems with smell, cough and dyspnoea.
本研究旨在评估30例成功接受喉切除术患者的术后生活质量(QoL)。
在定期门诊随访期间,使用两份经过验证的问卷(EORTC-QLQ-C30和EORTC-QLQ-H&N35)对生活质量进行评估。为了分析长期生活质量,我们将患者群体分为两组;一组由治疗完成时间不到五年的患者组成,另一组由治疗完成时间超过五年的患者组成。
患者群体包括24名男性(80%)和6名女性(20%),平均年龄为58.8±8.7岁。平均随访时间为53个月(范围:12 - 110个月)。大多数患者(n = 15,50%)根据国际抗癌联盟(UICC)标准处于肿瘤IV期。所有患者均使用Provoxreg语音假体实现了语音康复。总体生活质量评分为满意,平均值为62。对特定问卷的分析显示,大多数患者存在嗅觉受限问题。治疗时间超过五年的患者在总体生活质量方面略有改善。总体而言,我们未发现两组患者在生活质量方面存在显著差异。
在我们的研究中,喉切除患者的生活质量令人满意。最常见的症状是嗅觉问题、咳嗽和呼吸困难。